News & Events

Press Releases

Evergen Launches AI-powered Bone Graft Image Processing Software

February 3, 2025

RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine

December 17, 2024

RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction

November 25, 2024

RTI Surgical Completes Acquisition of Collagen Solutions

November 1, 2024

RTI Surgical Celebrates Expansion of Tutoplast® Tissue Sterilization Process Facility

October 30, 2024

RTI Surgical Completes Acquisition of Cook Biotech

January 31, 2024

RTI Surgical Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast Reconstruction

November 27, 2023

Empowered Patient Podcast: Customized Allograft and Xenograft Biomaterials for Use in Regenerative Medicine with Olivier Visa, Evergen

March 4, 2025

Healthcare Business Today: The Future of Regenerative Medicine: What’s Next in 2025 and Beyond by Olivier Visa

January 20, 2025

Medical Product Outsourcing: RTI Surgical Rebrands as Evergen, a Regenerative Medicine CDMO by Sam Brusco

December 17, 2024

Upcoming Events

Connect with us at an upcoming event

MEDevice Boston

Boston, MA

September 30 – October 1, 2025

Booth 1023

The MedTech Conference (AdvaMed)

San Diego, CA

October 5-8, 2025

Booth 701

Plastic Surgery The Meeting

New Orleans, LA

October 9-12, 2025

Booth 1627

MD&M Midwest 2025

Minneapolis, MN

October 21-22, 2025

Booth 3917

North American Spine Society (NASS) Annual Meeting

Denver CO

November 14-16, 2025

Booth 1829

MEDICA

Dusseldorf, Germany

November 17-20, 2025

Booth D 29-2

American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting

New Orleans, LA

March 2-6, 2026

Booth 3219

Leading innovation in regenerative medicine solutions

Press Releases

Evergen Launches AI-powered Bone Graft Image Processing Software

RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine

RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction

RTI Surgical Completes Acquisition of Collagen Solutions

RTI Surgical Celebrates Expansion of Tutoplast® Tissue Sterilization Process Facility

RTI Surgical Completes Acquisition of Cook Biotech

RTI Surgical Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast Reconstruction

In the News

Empowered Patient Podcast: Customized Allograft and Xenograft Biomaterials for Use in Regenerative Medicine with Olivier Visa, Evergen

Healthcare Business Today: The Future of Regenerative Medicine: What’s Next in 2025 and Beyond by Olivier Visa

Medical Product Outsourcing: RTI Surgical Rebrands as Evergen, a Regenerative Medicine CDMO by Sam Brusco

Upcoming Events

About Evergen

Services

Biomaterials

News & Events

Careers

Contact